Cost-effectiveness and Potential Impact of Rotavirus Vaccination in the United States
OBJECTIVE. In February 2006, a safe, efficacious, orally administered pentavalent human-bovine reassortant rotavirus vaccine was licensed and recommended for routine immunizatio...